Recent advances in lipoprotein and atherosclerosisa nutrigenomic approach

Referencias bibliográficas

• Abia R, Pacheco YM, Perona JS, Montero E, Muriana FJ, Ruiz-Gutiérrez V. 2001. The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. J Nutr. 131, 59-65.
• Alipour A, van Oostrom AJ, Izraeljan A, Verseyden C, Collins JM, Frayn KN, Plokker TW, Elte JW, Castro Cabezas M. 2008. Leukocyte activation by triglyceride-rich lipoproteins. Arterioscler. Thromb. Vasc. Biol. 28, 792-797. doi:10.1161/ATVBAHA.107.159749
• Arab L. 2004. Individualized nutritional recommendations: do we have the measurements needed to assess risk and make dietary recommendations? Proc. Nutr. Soc. 63, 167-172. doi:10.1079/PNS2003325 PMid:15070447
• Aramaki Y, Mitsuoka H, Toyohara M, Jinnai T, Kanatani K, Nakajima K, Mukai E, Yamada Y, Kita T, Inagaki N, Kume N. 2008. Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis 198, 272-279. doi:10.1016/j.atherosclerosis.2007.12.017 PMid:18282574
• Armah CK, Jackson KG, Doman I, James L, Cheghani F, Minihane AM. 2008. Fish oil fatty acids improve postprandial vascular reactivity in healthy men. Clin. Sci. (Lond), 114, 679-686. doi:10.1042/CS20070277 PMid:18052925
• Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298, 309-316. doi:10.1001/jama.298.3.309 PMid:17635891
• Bermúdez B, López S, Pacheco YM, Villar J, Muriana FJ, Hoheisel JD, Bauer A, Abia R. 2008. Influence of postprandial triglyceride-rich lipoproteins on lipidmediated gene expression in smooth muscle cells of the human coronary artery. Cardiovasc. Res. 79, 294-303. doi:10.1093/cvr/cvn082 PMid:18359786
• Berliner JA, Subbanagounder G, Leitinger N, Watson AD, Vora D. 2001. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends Cardiovasc. Med. 11, 142-147. doi:10.1016/S1050-1738(01)00098-6 PMid:11686004
• Bravo E, Napolitano M. 2007. Mechanisms involved in chylomicron remnant lipid uptake by macrophages. Biochem. Soc. Trans 35, 459-463. doi:10.1042/BST0350459 PMid:17511627
• Chen CY, Lee CM, Hsu HC, Yang CY, Chow LP, Lee YT. 2007. Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell. Life Sci.80, 2469-2480. doi:10.1016/j.lfs.2007.04.007 PMid:17509619
• Cohn JS. 2006. Postprandial lipemia and remnant lipoproteins. Clin. Lab. Med. 26, 773-786. doi:10.1016/j.cll.2006.07.003 PMid:17110239
• Dupont A, Chwastyniak M, Beseme O, Guihot AL, Drobecq H, Amouyel P, Pinet F. 2008. Application of saturation dye 2D-DIGE proteomics to characterize proteins modulated by oxidized low density lipoprotein treatment of human macrophages. J. Proteome Res. 7, 3572-3582. doi:10.1021/pr700683s PMid:18549265
• Fach EM, Garulacan LA, Gao J, Xiao Q, Storm SM, Dubaquie YP, Hefta SA, Opiteck GJ. 2004. In vitro biomarker discovery for atherosclerosis by proteomics. Mol. Cell. Proteomics 3, 1200-1210. doi:10.1074/mcp.M400160-MCP200
• Fitó M, Guxens M, Corella D, Sáez G, Estruch R, de la Torre R, Francés F, Cabezas C, López-Sabater Mdel C, Marrugat J, García-Arellano A, Arós F, Ruiz-Gutierrez V, Ros E, Salas-Salvadó J, Fiol M, Solá R, Covas MI; for the PREDIMED Study Investigators. 2007. Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch. Intern. Med. 167, 1195-1203. doi:10.1001/archinte.167.11.1195 PMid:17563030
• Frostegård J. 2005. Atherosclerosis in patients with autoimmune disorders. Arterioscler. Thromb. Vasc. Biol. 25, 1776-1785. doi:10.1161/01.ATV.0000174800.78362.ec
• Furtado JD, Campos H, Appel LJ, Miller ER, Laranjo N, Carey VJ, Sacks FM. 2008. Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. Am. J. Clin. Nutr. 87, 1623-1630.
• Galle J, Hansen-Hagge T, Wanner C, Seibold S. 2006. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185, 219-226. doi:10.1016/j.atherosclerosis.2005.10.005 PMid:16288760
• Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S, Nelson SF, Horvath S, Berliner JA, Kirchgessner TG, Lusis AJ. 2006. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc. Natl. Acad. Sci.U S A 103, 12741-12746. doi:10.1073/pnas.0605457103
• Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, Szeto WL, Watson AD, Lusis AJ, Berliner JA. 2007. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. Arterioscler. Thromb. Vasc. Biol. 27, 1346-53. doi:10.1161/ATVBAHA.107.141283
• Hammad SM, Twal WO, Barth JL, Smith KJ, Saad AF, Virella G, Scott Argraves W, Lopes-Virella MF. 2008. Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells. Atherosclerosis (Epub ahead of print) doi:10.1016/j.atherosclerosis.2008.05.032 PMid:18597759
• Hilpert KF, West SG, Kris-Etherton PM, Hecker KD, Simpson NM, Alaupovic P. 2007. Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein Bcontaining lipoproteins and vascular reactivity in type 2 diabetes. Am. J. Clin. Nutr. 85, 369-376.
• Hurtado I, Fiol C, Gracia V, Caldú P. 1996. In vitro oxidised HDL exerts a cytotoxic effect on macrophages. Atherosclerosis 125, 39-46. doi:10.1016/0021-9150(96)05840-6 PMid:8831925
• Jagla A, Schrezenmeir J. 2001. Postprandial triglycerides and endothelial function. Exp. Clin. Endocrinol. Diabetes 109, S533-547. doi:10.1055/s-2001-15116
• Kawakami A, Tanaka A, Chiba T, Nakajima K, Shimokado K, Yoshida M. 2003. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation 108, 2679-2688. doi:10.1161/01.CIR.0000093278.75565.87 PMid:14623816
• Kawakami A, Yoshida M. 2005. Remnant lipoproteins and atherogenesis. J. Atheroscler. Thromb. 12, 73-76.
• Kinumi T, Ogawa Y, Kimata J, Saito Y, Yoshida Y, Niki E. 2005. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL. Free Radic. Res. 39, 1335-1344. doi:10.1080/10715760500306695 PMid:16298863
• Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, Moriwaki H, Kataoka H, Nishi E, Horiuchi H, Arai H, Yokode M. 2001. Role of oxidized LDL in atherosclerosis. Ann. N. Y. Acad. Sci. 947, 199-205.
• Lopez-Miranda J, Williams C, Lairon D. 2007. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br. J. Nutr. 98,458-473. doi:10.1017/S000711450774268X PMid:17705891
• Levula M, Jaakkola O, Luomala M, Nikkari ST, Lehtimäki T. 2006. Effects of oxidized low- and high-density lipoproteins on gene expression of human macrophages. Scand. J. Clin. Lab. Invest.66, 497-508. doi:10.1080/00365510600836651 PMid:17000557
• Mikita T, Porter G, Lawn RM, Shiffman D. 2001. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J. Biol. Chem. 276, 45729-45739. doi:10.1074/jbc.M106114200 PMid:11577090
• Mora S, Rifai N, Buring JE, Ridker PM. 2008. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 118, 993-1001. doi:10.1161/CIRCULATIONAHA.108.777334 PMid:18711012
• Nakamura T, Takano H, Umetani K, Kawabata K, Obata JE, Kitta Y, Kodama Y, Mende A, Ichigi Y, Fujioka D, Saito Y, Kugiyama K. 2005. Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis 181, 321-327. doi:10.1016/j.atherosclerosis.2005.01.012 PMid:16039286
• Nicholls SJ, Lundman P, Harmer JA, Cutri B, Griffiths KA, Rye KA, Barter PJ, Celermajer DS. 2006. Consumption of saturated fat impairs the antiinflammatory properties of high-density lipoproteins and endothelial function. J. Am. Coll. Cardiol. 48, 715-720. doi:10.1016/j.jacc.2006.04.080 PMid:16904539
• Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. 2007. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299-308. doi:10.1001/jama.298.3.299 PMid:17635890
• Norata GD, Grigore L, Raselli S, Redaelli L, Hamsten A, Maggi F, Eriksson P, Catapano AL. 2007. Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis 193, 321-327. doi:10.1016/j.atherosclerosis.2006.09.015 PMid:17055512
• Norata GD, Grigore L, Raselli S, Seccomandi PM, Hamsten A, Maggi FM, Eriksson P, Catapano AL. 2006. Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies. J. Mol. Cell. Cardiol. 40, 484-494. doi:10.1016/j.yjmcc.2006.01.022 PMid:16516917
• Norata GD, Pirillo A, Callegari E, Hamsten A, Catapano AL, Eriksson P. 2003. Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovasc. Res. 59, 169-180. doi:10.1016/S0008-6363(03)00335-3 PMid:12829188
• Pacheco YM, Abia R, Perona JS, Meier KE, Montero E, Ruiz-Gutiérrez V, Muriana FJ. 2002. Triacylglycerolrich lipoproteins trigger the phosphorylation of extracellular-signal regulated kinases in vascular cells. Life Sci. 71, 1351-1360. doi:10.1016/S0024-3205(02)01860-X PMid:12127156
• Padró T, Peña E, García-Arguinzonis M, Llorente-Cortes V, Badimon L. 2008. Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain. Cardiovasc. Res. 77, 211-220. doi:10.1093/cvr/cvm045 PMid:18006454
• Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP. 1994. Triglyceriderich lipoproteins isolated by selected-affinity antiapolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler. Thromb. 14, 1767-1774.
• Reeve JL, Stenson-Cox C, O’Doherty A, Pörn-Ares I, Ares M, O’Brien T, Samali A. 2007. OxLDL-induced gene expression patterns in CASMC are mimicked in apoE-/- mice aortas. Biochem. Biophys. Res. Commun. 356, 681-686. doi:10.1016/j.bbrc.2007.03.027 PMid:17374365
• Saad AF, Virella G, Chassereau C, Boackle RJ, Lopes-Virella MF. 2006. OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages. J. Lipid. Res. 47, 1975-1983. doi:10.1194/jlr.M600064-JLR200
• Subbiah MT. 2008. Understanding the nutrigenomic definitions and concepts at the food-genome junction. OMICS 12, (Epub ahead of print)
• Sukhanov S, Delafontaine P. 2005. Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells. Proteomics 5, 1274-1280. doi:10.1002/pmic.200400985 PMid:15732133
• Sukhanov S, Hua Song Y, Delafontaine P. 2003. Global analysis of differentially expressed genes in oxidized LDL-treated human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 306, 443-449. doi:10.1016/S0006-291X(03)00990-2 PMid:12804583
• Tall AR. 2008. Cholesterol efflux pathways and other potential mechanisms involved in the atheroprotective effect of high density lipoproteins. J. Intern. Med. 263, 256-273. doi:10.1111/j.1365-2796.2007.01898.x PMid:18271871
• Thompson SM, Arrowsmith FE, Allen JR. 2003. Dietary management of galactosemia. Southeast Asian J. Trop. Med. Public. Health 34, 212-214.
• Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB. 2005. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N. Engl. J. Med. 353, 46-57. doi:10.1056/NEJMoa043175 PMid:16000355
• Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F, Xu Q, Bergmark C, Weger S, Oberhollenzer F, Witztum JL. 2006. Oxidised phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. J. Am. Col. Cardiol. 47, 2219–2228. doi:10.1016/j.jacc.2006.03.001 PMid:16750687
• Valiyaveettil M, Kar N, Ashraf MZ, Byzova TV, Febbraio M, Podrez EA. 2008. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood 111, 1962-1971. doi:10.1182/blood-2007-08-107813 PMid:17993610
• van Spronsen FJ, van Rijn M, Bekhof J, Koch R, Smit PG. 2001. Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets. Am. J. Clin. Nutr.73, 153-157.
• Virgili F, Ambra R, Muratori F, Natella F, Majewicz J, Minihane AM, Rimbach G. 2003. Effect of oxidized low-density lipoprotein on differential gene expression in primary human endothelial cells. Antioxid. Redox Signal 5, 237-247. doi:10.1089/152308603764816596 PMid:12716483
• Williams CM, Maitin V, Jackson KG. 2004. Triacylglycerolrich lipoprotein-gene interactions in endothelial cells. Biochem. Soc. Trans 32, 994-998. doi:10.1042/BST0320994 PMid:15506945
• Yang PY, Rui YC, Yang PY, Yu YL. 2007. Proteomic analysis of foam cells. Methods Mol. Biol. 357, 297-305.
• Yu YL, Huang ZY, Yang PY, Rui YC, Yang PY. 2003. Proteomic studies of macrophage-derived foam cell from human U937 cell line using two-dimensional gel electrophoresis and tandem mass spectrometry. J. Cardiovasc. Pharmacol. 42, 782-789. doi:10.1097/00005344-200312000-00013 PMid:14639101